Phase 1 clinical trial of MOL4239 in healthy volunteers
Latest Information Update: 19 Jun 2017
At a glance
- Drugs WP 1220 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
Most Recent Events
- 19 Jun 2017 New trial record
Latest Information Update: 19 Jun 2017